First patient dosed for the first week in NG11-2 Phase Ib clinical trial Gallery First patient dosed for the first week in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2025-02-17T11:59:27+00:00May 26th, 2023|Clinical Development, News, NG11| Read More
First patient enrolled in NG11-2 Phase Ib clinical trial Gallery First patient enrolled in NG11-2 Phase Ib clinical trial By Chloe Atkinson|2025-02-17T12:51:47+00:00May 8th, 2023|Clinical Development, News, NG11| Read More
VasoDynamics Receives Global Health and Pharma Biotechnology 2023 Award Gallery VasoDynamics Receives Global Health and Pharma Biotechnology 2023 Award By Chloe Atkinson|2025-02-17T12:47:05+00:00April 12th, 2023|News| Read More
VasoDynamics Receives UK MHRA-REC Approval On NG11-2 Phase Ib Clinical Trial Gallery VasoDynamics Receives UK MHRA-REC Approval On NG11-2 Phase Ib Clinical Trial By Chloe Atkinson|2025-02-17T12:45:13+00:00January 24th, 2023|Clinical Development, News, NG11| Read More
VasoDynamics files UK patent for Radiotherapy-Induced Oral Mucositis (RIOM) Clinical Trial Methodology Gallery VasoDynamics files UK patent for Radiotherapy-Induced Oral Mucositis (RIOM) Clinical Trial Methodology By Chloe Atkinson|2025-02-17T12:44:34+00:00December 22nd, 2022|Clinical Development, News| Read More
VasoDynamics submits UK Clinical Trial Application for NG11-2 Gallery VasoDynamics submits UK Clinical Trial Application for NG11-2 By Chloe Atkinson|2025-02-17T12:44:08+00:00October 21st, 2022|Clinical Development, News, NG11| Read More
VasoDynamics establishes Clinical and Scientific Advisory Board Gallery VasoDynamics establishes Clinical and Scientific Advisory Board By Chloe Atkinson|2025-02-17T12:43:30+00:00July 30th, 2022|Corporate Development, News| Read More
VasoDynamics selects clinical trial sites across the UK and appoints Chief Investigator Gallery VasoDynamics selects clinical trial sites across the UK and appoints Chief Investigator By Chloe Atkinson|2025-02-17T12:42:34+00:00June 30th, 2022|Corporate Development, News| Read More
VasoDynamics files global patent (PCT) for NG11-2 platform formulation and production Gallery VasoDynamics files global patent (PCT) for NG11-2 platform formulation and production By Chloe Atkinson|2025-02-17T12:42:10+00:00March 5th, 2022|Clinical Development, News, NG11| Read More
VasoDynamics strengthens Board and management team with key appointments Gallery VasoDynamics strengthens Board and management team with key appointments By Chloe Atkinson|2025-02-17T12:41:29+00:00January 10th, 2022|Corporate Development, News| Read More
